30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Episurf Hears FDA Feedback on IDE for Episealer Knee -

Episurf Medical is entering its next phase for Investigational Device Exemption (IDE) to initiate a U.S. clinical study of the Episealer® knee implant, having submitted its application in mid-2Q18. The company has additional details to address for FDA prior to setting a finalized IDE study design. (Episurf Medical AB, 7/30/18)